These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 18947995)

  • 21. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.
    Sofia MJ; Chang W; Furman PA; Mosley RT; Ross BS
    J Med Chem; 2012 Mar; 55(6):2481-531. PubMed ID: 22185586
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase.
    Tomei L; Altamura S; Paonessa G; De Francesco R; Migliaccio G
    Antivir Chem Chemother; 2005; 16(4):225-45. PubMed ID: 16130521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.
    Li LS; Zhou Y; Murphy DE; Stankovic N; Zhao J; Dragovich PS; Bertolini T; Sun Z; Ayida B; Tran CV; Ruebsam F; Webber SE; Shah AM; Tsan M; Showalter RE; Patel R; Lebrun LA; Bartkowski DM; Nolan TG; Norris DA; Kamran R; Brooks J; Sergeeva MV; Kirkovsky L; Zhao Q; Kissinger CR
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3446-55. PubMed ID: 18457949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.
    Wyles DL; Kaihara KA; Schooley RT
    Antimicrob Agents Chemother; 2008 May; 52(5):1862-4. PubMed ID: 18332167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
    Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-hydrolysable analogs of inorganic pyrophosphate as inhibitors of hepatitis C virus RNA-dependent RNA-polymerase].
    Ianvarev DV; Korovina AN; Usanov NN; Kochetkov SN
    Bioorg Khim; 2012; 38(2):257-62. PubMed ID: 22792731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.
    Maynard A; Crosby RM; Ellis B; Hamatake R; Hong Z; Johns BA; Kahler KM; Koble C; Leivers A; Leivers MR; Mathis A; Peat AJ; Pouliot JJ; Roberts CD; Samano V; Schmidt RM; Smith GK; Spaltenstein A; Stewart EL; Thommes P; Turner EM; Voitenleitner C; Walker JT; Waitt G; Weatherhead J; Weaver K; Williams S; Wright L; Xiong ZZ; Haigh D; Shotwell JB
    J Med Chem; 2014 Mar; 57(5):1902-13. PubMed ID: 23672667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.
    Nichols DB; Fournet G; Gurukumar KR; Basu A; Lee JC; Sakamoto N; Kozielski F; Musmuca I; Joseph B; Ragno R; Kaushik-Basu N
    Eur J Med Chem; 2012 Mar; 49():191-9. PubMed ID: 22280819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
    Ruebsam F; Sun Z; Ayida BK; Webber SE; Zhou Y; Zhao Q; Kissinger CR; Showalter RE; Shah AM; Tsan M; Patel R; Lebrun LA; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Kirkovsky L
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5002-5. PubMed ID: 18722768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy.
    Wu JZ; Hong Z
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):207-19. PubMed ID: 14529354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
    Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity.
    Laporte MG; Jackson RW; Draper TL; Gaboury JA; Galie K; Herbertz T; Hussey AR; Rippin SR; Benetatos CA; Chunduru SK; Christensen JS; Coburn GA; Rizzo CJ; Rhodes G; O'Connell J; Howe AY; Mansour TS; Collett MS; Pevear DC; Young DC; Gao T; Tyrrell DL; Kneteman NM; Burns CJ; Condon SM
    ChemMedChem; 2008 Oct; 3(10):1508-15. PubMed ID: 18729128
    [No Abstract]   [Full Text] [Related]  

  • 35. Allosteric inhibition of the hepatitis C virus NS5B RNA dependent RNA polymerase.
    Koch U; Narjes F
    Infect Disord Drug Targets; 2006 Mar; 6(1):31-41. PubMed ID: 16787302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication.
    Nilsson M; Kalayanov G; Winqvist A; Pinho P; Sund C; Zhou XX; Wähling H; Belfrage AK; Pelcman M; Agback T; Benckestock K; Wikström K; Boothee M; Lindqvist A; Rydegård C; Jonckers TH; Vandyck K; Raboisson P; Lin TI; Lachau-Durand S; de Kock H; Smith DB; Martin JA; Klumpp K; Simmen K; Vrang L; Terelius Y; Samuelsson B; Rosenquist S; Johansson NG
    Bioorg Med Chem Lett; 2012 May; 22(9):3265-8. PubMed ID: 22472694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity.
    Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Hofmann GA; Slater MJ; Haigh D; Dhanak D; Johnson VK; Parry NR; Thommes P
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1930-3. PubMed ID: 17270443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase.
    Zheng BZ; D'Andrea SV; Hanumegowda U; Knipe JO; Mosure K; Zhuo X; Lemm JA; Liu M; Rigat KL; Wang YK; Fang H; Poronsky C; Cutrone J; Wu DR; Arunachalam PN; Balapragalathan TJ; Arumugam A; Mathur A; Meanwell NA; Gao M; Roberts SB; Kadow JF
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3294-3300. PubMed ID: 28633899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
    Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.